Healthcare

Image

Global Human Rotavirus Vaccine Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Jul 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Human Rotavirus Vaccine Market, By type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others), End Users (Hospitals and Clinics, Academic and Research, Others), Application (Hospitals and Clinics, Academic and Research) - Industry Trends and Forecast to 2030.

Human Rotavirus Vaccine Market

Human Rotavirus Vaccine Market Analysis and Size

Major factors that are expected to boost the growth of the human rotavirus vaccine market in the forecast period are the rise in the development, the upsurge in the number of immunity-compromised people and the increase in alertness amongst the people. Furthermore, the rise in the elderly population and the increase in the general population and live births are a couple of factors further propelling the growth of the human rotavirus vaccine market.

Data Bridge Market Research analyzes that the global human rotavirus vaccine market which was USD  7.20 billion in 2022, would rocket up to USD 10.36 billion by 2030, and is expected to undergo a CAGR of 6.2% during the forecast period 2023 to 2030. This indicates the market value. “Rotarix” dominates the type segment of the global human rotavirus vaccine market owing to the surge in the number of people suffering from viral disease. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Human Rotavirus Vaccine Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, others), End Users (Hospitals and Clinics, Academic and Research, Others), Application (Hospitals and Clinics, Academic and Research)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa

Market Players Covered

Merck & Co., Inc. (US), Bharat Biotech (India), GlaxoSmithKline plc. (UK), Sanofi (France), Lanzhou Institute of Biologicals Products Co., Ltd (China), BIOVIRx Inc (US), Serum Institute of India Pvt. Ltd. (India), Biological E (India), Bio Farma (Indonesia), Novartis AG (Switzerland), Berghofer Medical Research Institute (Australia), Pfizer, Inc (USA), among other.  

Market Opportunities

  • Increase in the number of research and development activities
  • Development of vaccines 

Market Definition

The Rotavirus vaccine is applied to prevent rotavirus infections which can cause severe diarrhea among young children. Symptoms of rotavirus infection consist of severe diarrhea, vomiting, fever, and abdominal pain, which can cause the disease. The Rotavirus vaccine is given by mouth and requires two or three doses starting around six weeks of age.

Global Human Rotavirus Vaccine Market Dynamics  

Drivers

Advancements in Vaccine Discovery and Manufacturing

Due to advancements in vaccine discovery and manufacturing, the Human Rotavirus Vaccine Market is quickly growing. Furthermore, the market expansion is being fueled by the growing geriatric population as well as raising public awareness.

Increased Vaccine Production

The Human Rotavirus Vaccine Market is expanding due to increased vaccine production. Rotavirus immunization protects children against rotavirus infections, which cause diarrhea. Severe diarrhea, vomiting, fever, and abdominal pain are all indications of rotavirus infection, which can lead to illness. Beginning about the age of six weeks, rotavirus vaccination is given orally in two or three doses.

Opportunities

Increase in Incidences of Human Rotavirus Infection

This increase in incidences is expected to drive the Human Rotavirus Vaccine Market during the forecast period, according to estimates. Various organizations, including UNICEF and GAVI, have urged for the use of the rotavirus vaccine in various countries to enhance immunization coverage and deliver immunizations at a lower cost, hence reducing illness instances and promoting a healthy lifestyle.   

Restraints/Challenges

High cost of vaccines:

The rise in vaccination prices and the vaccine’s unpleasant reactions and side effects would all stymie the market’s growth soon. The potential of bioterrorism and strict regulatory standards for the approval of novel human rotavirus vaccines are the main hindrance to the market.

Recent Development

  • In 2017, the Serum Institute of India Pvt. Ltd. revealed the result of a clinical trial Phase 3 efficacy study of the rotavirus vaccine BRV-PV, ROTASIIL. The study has shown that the vaccine is safe, well tolerated, and provides significant efficacy against severe rotavirus gastroenteritis  

Global Human Rotavirus Vaccine Market Scope

The global human rotavirus vaccine market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Rotarix
  • Rotateq
  • Rotavac
  • Rotavin-M1
  • Lanzhou Lamb
  • Others

Application

  • Hospitals and Clinics
  • Academic and Research

End User

  • Hospitals and Clinics
  • Academic and Research
  • Others

Global Human Rotavirus Vaccine Market Regional Analysis/Insights

The global human rotavirus vaccine market is analyzed and market size insights and trends are provided by country, type, application and end user, as referenced above.    

The countries covered in the global human rotavirus vaccine market report are the U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa.     

North America is expected to dominate the global human rotavirus vaccine market because of the strong base of healthcare facilities, the strong presence of major players in the market, increasing cases of viral infections and rising number of research activities in this region.      

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, a large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global human rotavirus vaccine market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global human rotavirus vaccine market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global human rotavirus vaccine market. The data is available for the historic period 2015-2020.       

Competitive Landscape and Global Human Rotavirus Vaccine Market Share Analysis

The global human rotavirus vaccine market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.     

Some of the major players operating in the global human rotavirus vaccine market are:  

  • Merck & Co., Inc. (US),
  • Bharat Biotech (India),
  • GlaxoSmithKline plc. (UK),
  • Sanofi (France),
  • Lanzhou Institute of Biologicals Products Co., Ltd (China),
  • BIOVIRx Inc (US),
  • Serum Institute of India Pvt. Ltd. (India),
  • Biological E (India),
  • Bio Farma (Indonesia),
  • Novartis AG (Switzerland),
  • Berghofer Medical Research Institute (Australia),
  • Pfizer, Inc (USA)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Human Rotavirus Vaccine Market will be worth USD 10.36 billion by 2030.
The Human Rotavirus Vaccine Market Growth Rate is 6.2% during the forecast period.
The Advancements in Vaccine Discovery and Manufacturing and Increased Vaccine Production are the Growth Drivers of the Human Rotavirus Vaccine Market.
The type, application, and end-user are the factors on which the Human Rotavirus Vaccine Market research is based.
The Serum Institute of India Pvt. Ltd. revealed the result of a clinical trial Phase 3 efficacy study of the rotavirus vaccine BRV-PV, ROTASIIL is the latest development in the Human Rotavirus Vaccine Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials